ストックスクリーナーアプリを入手
117.65
3.51%
-4.28
プレマーケット:
117.40
-0.25
-0.21%
前日終値:
$121.93
開ける：
$121.41
24時間の取引高:
16.15M
Relative Volume:
1.12
時価総額：
$292.01B
収益：
$65.00B
当期純損益:
$18.26B
株価収益率:
16.17
EPS:
7.2751
ネットキャッシュフロー:
$13.05B
1週間 パフォーマンス:
+3.78%
1か月 パフォーマンス:
+6.44%
6か月 パフォーマンス:
+45.80%
1年 パフォーマンス:
+34.80%
1日の値動き範囲:
$116.98
$121.88
1週間の範囲:
$111.44
$122.66
52週間の値動き範囲:
$73.31
$122.66
Merck Co Inc Stock (MRK) Company Profile
Compare MRK vs LLY, JNJ, ABBV, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
117.65 | 302.63B | 65.00B | 18.26B | 13.05B | 7.2751 |
|
LLY
Lilly Eli Co
|
1,044.67 | 947.09B | 65.18B | 20.64B | 6.44B | 22.96 |
|
JNJ
Johnson Johnson
|
238.64 | 578.21B | 94.19B | 26.80B | 20.46B | 11.05 |
|
ABBV
Abbvie Inc
|
223.26 | 394.89B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
NVS
Novartis Ag Adr
|
157.05 | 298.47B | 54.72B | 14.02B | 15.32B | 7.1855 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-08 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-10-13 | 再開されました | Citigroup | Neutral |
| 2025-09-17 | ダウングレード | Berenberg | Buy → Hold |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Neutral |
| 2025-02-18 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-02-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-01-08 | ダウングレード | Truist | Buy → Hold |
| 2024-12-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-12-04 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-11 | ダウングレード | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-03-11 | ダウングレード | Societe Generale | Hold → Sell |
| 2024-01-04 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-10-27 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | アップグレード | UBS | Neutral → Buy |
| 2023-07-14 | 開始されました | HSBC Securities | Hold |
| 2023-04-13 | アップグレード | Citigroup | Neutral → Buy |
| 2023-03-28 | ダウングレード | Societe Generale | Buy → Hold |
| 2023-03-13 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 開始されました | Jefferies | Buy |
| 2023-02-22 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-10-10 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-09-14 | アップグレード | Berenberg | Hold → Buy |
| 2022-07-06 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 再開されました | SVB Leerink | Outperform |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 開始されました | Goldman | Buy |
| 2021-12-16 | 開始されました | Daiwa Securities | Neutral |
| 2021-12-13 | ダウングレード | UBS | Buy → Neutral |
| 2021-12-09 | 開始されました | Wells Fargo | Overweight |
| 2021-12-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-11-29 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-11-01 | アップグレード | Argus | Hold → Buy |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-05-20 | ダウングレード | Argus | Buy → Hold |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-08-03 | アップグレード | Goldman | Neutral → Buy |
| 2020-06-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-16 | 開始されました | SVB Leerink | Outperform |
| 2019-07-03 | 開始されました | Mizuho | Buy |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-05-13 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 繰り返されました | Citigroup | Buy |
| 2018-10-09 | 再開されました | Guggenheim | Buy |
| 2018-04-23 | アップグレード | Goldman | Neutral → Buy |
| 2018-04-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-03-12 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2018-02-07 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2018-01-16 | アップグレード | SunTrust | Hold → Buy |
すべてを表示
Merck Co Inc (MRK) 最新ニュース
Should You Buy Moderna Before Feb. 13? - The Motley Fool
Insider Sell: Chirfi Guindo Sells 10,000 Shares of Merck & Co In - GuruFocus
Merck & Co., Inc. (NYSE:MRK) EVP Sells $14,485,422.95 in Stock - MarketBeat
Chirfi Guindo Sells 10,000 Shares of Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck: The Spike Doesn't Make It Overvalued (NYSE:MRK) - Seeking Alpha
Merck Stock Surged 40% Last Year. Is it Still a Buy in 2026? - TIKR.com
Merck: A Buy For 2026, But The Clock Is Still Ticking (NYSE:MRK) - Seeking Alpha
Oppenheimer Asset Management Inc. Has $46.50 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Alps Advisors Inc. Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Reduced by Candriam S.C.A. - MarketBeat
From Bargain To Balancing Act: Merck's Next Test Begins (Rating Downgrade) - Seeking Alpha
Merck: Pipeline Building Despite The Light FY26 Guide, Major Momentum - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Cut to "Buy" at Wall Street Zen - MarketBeat
Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface - TechStock²
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
Merck & Co., Inc. $MRK Shares Bought by Canada Post Corp Registered Pension Plan - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Garland Capital Management Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Prime Capital Investment Advisors LLC - MarketBeat
Insider Sell Alert: Johannes Oosthuizen Sells 15,000 Shares of M - GuruFocus
Merck & Co., Inc. (NYSE:MRK) EVP David Michael Williams Sells 5,000 Shares - MarketBeat
Johannes Jacobus Oosthuizen Sells 15,000 Shares of Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck & Co., Inc. (NYSE:MRK) CFO Caroline Litchfield Sells 41,997 Shares - MarketBeat
Merck And Company Inc (NYSE:MRK) Healthcare Momentum In S&P 500 Today - Kalkine Media
Merck & Co., Inc. (NYSE:MRK) Shares Up 1.8% Following Analyst Upgrade - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $140.00 - MarketBeat
Willis Investment Counsel Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Guggenheim Adjusts Price Target on Merck & Co to $140 From $122, Maintains Buy Rating - marketscreener.com
Merck & Co., Inc. $MRK Holdings Cut by Fishman Jay A Ltd. MI - MarketBeat
Bessemer Group Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.1% on Analyst Upgrade - MarketBeat
Scotiabank Lifts Merck (MRK) Target as Execution Continues to Impress - Finviz
Merck stock rises 2% in New York as MRK traders size up outlook and a fresh RSV approval - TechStock²
Merck veteran Perlmutter-led Eikon Therapeutics valued at $860 million in Nasdaq debut - Reuters
Savant Capital LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Triglav Investments D.O.O. - MarketBeat
Envestnet Asset Management Inc. Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
ABN AMRO Bank N.V. Acquires 37,932 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Holdings Lowered by Homestead Advisers Corp - MarketBeat
Merck & Co., Inc. $MRK Position Increased by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Merck Veteran-Led Eikon Therapeutics Raises $381 Million in IPO - Bloomberg
Merck & Co., Inc. (NYSE:MRK) Trading 2.2% Higher Following Earnings Beat - MarketBeat
Where is Merck & Co. (MRK) headed according to Wall Street? - MSN
Jim Cramer on Merck & Co.: “This is one of my favorite pharmaceutical stocks” - MSN
Jim Cramer on Merck & Co.: "This Is One of My Favorite Pharmaceutical Stocks" - Finviz
Jim Cramer on Merck & Co.: “This Is One of My Favorite Pharmaceutical Stocks” - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $120.00 at Citigroup - MarketBeat
Merck & Co Inc (NYSE:MRK) Tops Estimates - FXDailyReport.Com
Looking Into Merck & Co Inc's Recent Short Interest - Benzinga
Cantor Fitzgerald Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Wells Fargo & Company Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Q4 2025 Earnings Call Transcript - Insider Monkey
Merck Co Inc (MRK) 財務データ
収益
当期純利益
現金流量
EPS
2.60%
0.40%
大文字化:
|
ボリューム (24 時間):